Tie-2 inhibitor 7 is primarily utilized in research settings to study angiogenesis, the process by which new blood vessels form from pre-existing vessels. It specifically targets the Tie-2 receptor, a key player in vascular development and stability. By inhibiting this receptor, researchers can better understand its role in various physiological and pathological conditions, such as cancer, where angiogenesis is often dysregulated. This compound is also explored for its potential therapeutic applications in diseases characterized by abnormal blood vessel growth, including certain types of tumors and retinal disorders. Its use in preclinical studies helps in the development of targeted therapies aimed at controlling angiogenesis.